EFFICACY AND SAFETY OF EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) IN PIELIC STONES AND INFECTED HYDRONEPHROSIS AFTER DOUBLE-J STENT INSERTION

Authors

  • V.D. RADU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • R.C. COSTACHE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • P. ONOFREI “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • B. NOVAC “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • R.F. ANDRICIUC “C. I. Parhon” University Hospital, Iasi, Romania
  • R. OUATU “C. I. Parhon” University Hospital, Iasi, Romania
  • D. ARSENI “C. I. Parhon” University Hospital, Iasi, Romania
  • T.F. PANTILIMONESCU “C. I. Parhon” University Hospital, Iasi, Romania
  • Carina-Alexandra BANDAC “C. I. Parhon” University Hospital, Iasi, Romania

Abstract

Extracorporeal shockwave lithotripsy (ESWL), along with flexible retrograde ureteroscopy (RIRS), is the treatment of first choice for pelvic stones up to 10 mm, and double-J catheters are not routinely inserted prior to the procedure. However, their insertion is mandatory in patients with infected secondary hydronephrosis. The aim of the study was to evaluate the efficacy and safety of ESWL in this particular group of patients compared to patients without double-J ureteral catheters. Materials and methods: We conducted a retrospective case-control study of patients with pelvic stones up to 10 mm in whom a double-J ureteral catheter was inserted due to infected hydronephrosis and subsequently underwent ESWL between January 1, 2018 and December 31, 2023. As a control group, we included the patients with pelvic stones without a double-J catheter who underwent ESWL during the same period. We analyzed the demographic data, the stone-free rate and the occurrence of complications in the two patient groups. Results: We identified a number of 46 patients with double-J catheters and a number of 118 patients without double-J catheters who underwent ESWL for pelvic stones up to 10 mm. Patients in both groups were over 46 years of age, were predominantly male and had a body mass index (BMI) between 25 and 29.9. There were no statistically significant differences between the 2 groups in terms of stone-free rate, both after the first (78.3% vs. 73.7%, p=0.866), second (89.58% vs. 89.8%) and third ESWL sessions (93.7% vs. 95.7%, p=0.583). The complication rate was reduced in both groups, with no statistically significant differences (14.6% vs. 6.77%, p=0.324). Conclusions: The presence of double-J ureteral catheters inserted due to infected hydronephrosis did not reduce the efficacy of ESWL in patients with pelvic stones up to 10 mm. In this patient group, ESWL can be recommended as a first-line treatment alongside RIRS.

Author Biographies

  • V.D. RADU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgical Specialties (II)
    “C. I. Parhon” University Hospital, Iasi, Romania
    3. Department of Urology and Renal Transplantation

  • R.C. COSTACHE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgical Specialties (II)
    “C. I. Parhon” University Hospital, Iasi, Romania
    Department of Urology and Renal Transplantation

  • P. ONOFREI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Department of Morpho-Functional Sciences (II)
    “Elytis Hope” Hospital, Iasi, Romania
    Department of Urology

  • B. NOVAC, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Department of Surgical Specialties (II)
    “C. I. Parhon” University Hospital, Iasi, Romania
    Department of Urology and Renal Transplantation

  • R.F. ANDRICIUC, “C. I. Parhon” University Hospital, Iasi, Romania

    Department of Urology and Renal Transplantation

  • R. OUATU, “C. I. Parhon” University Hospital, Iasi, Romania

    Department of Urology and Renal Transplantation

  • D. ARSENI, “C. I. Parhon” University Hospital, Iasi, Romania

    Department of Urology and Renal Transplantation

  • T.F. PANTILIMONESCU, “C. I. Parhon” University Hospital, Iasi, Romania

    Department of Urology and Renal Transplantation

  • Carina-Alexandra BANDAC, “C. I. Parhon” University Hospital, Iasi, Romania

    Department of Urology and Renal Transplantation

References

1. Skolarikos A, Jung H, Neisius A et al. EAU Guidelines on Urolothiasis. In: EAU Guidelines, Edn. presented at the EAU Annual Congress Milan 2023. EAU Guidelines Office, Arnhem, The Nether-lands, 2023, 31-36.
2. Gürbüz ZG, Şener NC, Vuruşkan E, et al. Small renal pelvis stones: Shock wave lithotripsy or flexible ureteroscopy? A match-pair analysis. Turk J Urol 2018; 45(3): 202-205.
3. Khanna A, Monga M, Sun D, et al. Ureteral Stent Placement During Shockwave Lithotripsy: Charac-terizing Guideline Discordant Practice. Urology 2019; 133: 67-71.
4. Chandhoke PS, Barqawi AZ, Wernecke C, Chee-Awai RA. A randomized outcomes trial of ureteral stents for extracorporeal shock wave lithotripsy of solitary kidney or proximal ureteral stones. J Urol 2002; 167(5): 1981-1983.
5. Binu J, Vysakh R. Effect of stenting and non-stenting prior to extracorporeal shock wave lithotripsy of inferior caliceal stones: a comparative study. International Surgery Journal 2016; 3(1): 226-229.
6. Sharma R, Choudhary A, Das RK, et al. Can a brief period of double J stenting improve the outcome of extracorporeal shock wave lithotripsy for renal calculi sized 1 to 2 cm? Investig Clin Urol. 2017; 58(2): 103-108.
7. Menon WA, El Khalid S, Sharif I, et al. The efficacy of JJ Stent on Stone Free Rate After Extracorpo-real Shock Wave Lithotripsy: A Retrospective Study. Pakistan Journal of Medicine and Dentistry 2021; 10(2): 102-106.
8. Venugopal AV, Shammugha Das KW, Bhavish VS., Cardosa F. The effect of double j stent on the efficacy of extracorporeal shock wave lithotripsy in the treatment of ureteral stones. Int J Adv Res 2018; 6(2): 1-6.
9. Pettenati C, El Fegoun AB, Hupertan V, et al. Double J stent reduces the efficacy of extracorporeal shock wave lithotripsy in the treatment of lumbar ureteral stones. Cent European J Urol 2013; 66(3): 309-313.
10. Pansota MS, Shafquat S, Tabassum SA, et al. comparison of the success of extracorporeal shock wave lithotripsy (ESWL) with and without DJ stenting in proximal ureteric stones. Journal of University Medical and Dental College 2020; 11(2): 21-26.
11. Onen A. Grading of Hydronephrosis: An Ongoing Challenge. Front Pediatr 2020; 8: 458.
12. Tokas T, Habicher M, Junker D, et al. Training Research in Urological Surgery Technology (T.R.U.S.T.)-Group. Uncovering the real outcomes of active renal stone treatment by utilizing non-contrast computer tomography: a systematic review of the current literature. World J Urol 2017; 35(6): 897-905.
13. Bres-Niewada E. Is there a place for ESWL in the treatment of complicated proximal ureteral stones? Cent European J Urol 2013; 66(3): 314-315.
14. Radu VD, Ristescu C, Tomac I, et al. Does long preoperative ureteral double J stenting influence the outcomes of retrograde ureteroscopy for ureteral stones? A matched-paired case-control study. Med Surg J 2021; 125(2) :274-279.
15. Assimos D, Krambeck A, Miller NL, et al. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016; 196(4): 1153-1160.
16. Malinaric R, Mantica G, Martini M, et al. The Lifetime History of the First Italian Public Extra-Corporeal Shock Wave Lithotripsy (ESWL) Lithotripter as a Mirror of the Evolution of Endourology over the Last Decade. Int J Environ Res Public Health 2023; 20(5): 4127.
17. Musa AA. Use of double-J stents prior to extracorporeal shock wave lithotripsy is not beneficial: results of a prospective randomized study. Int Urol Nephrol. 2008; 40(1): 19-22.
18. Lawrentschuk N, Russell JM. Ureteric stenting 25 years on: routine or risky? ANZ J Surg 2004; 74(4): 243-247.
19. Radu VD, Vasilache IA, Costache RC, et al. Pregnancy Outcomes in a Cohort of Patients Who Un-derwent Double-J Ureteric Stenting-A Single Center Experience. Medicina (Kaunas) 2022; 58(5): 619 / doi: 10.3390/medicina58050619.
20. Shen P, Jiang M, Yang J, et al. Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J Urol. 2011; 186(4): 1328-1335.
21. Radu VD, Costache RC, Onofrei P, et al. Multidrug-Resistant (MDR) Urinary Tract Infections Asso-ciated with Gut Microbiota in CoV and Non-CoV Patients in a Urological Clinic during the Pandemic: A Single Center Experience. Antibiotics 2023; 12: 973.
22. Radu VD, Costache RC, Onofrei P, et al. Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic. Medicina (Kaunas) 2023; 59(11): 1972 / doi: 10.3390/medicina59111972.
23. Dyer RB, Chen MY, Zagoria RJ, et al. Complications of ureteral stent placement. Radiographics 2002; 22(5): 1005-1022.
24. Bejan C, Loghin I, Rosu F, et al. Clinical Features and Evolution of organ dysfunctions in sepsis Med Surg J 2014; 118(1): 71-74.
25. Low RK, Stoller ML, Irby P, et al. Outcome assessment of double-J stents during extracorporeal shockwave lithotripsy of small solitary renal calculi. J Endourol 1996; 10(4): 341-343.
26. Mohayuddin N, Malik HA, Hussain M, et al. The outcome of extracorporeal shockwave lithotripsy for renal pelvic stone with and without JJ stent-a comparative study. J Pak Med Assoc 2009; 59(3): 143-146.
27. Chiou YE, Chung CH, Chien WC, et al. A Comparative Study of Stone Re-Treatment after Lithotripsy. Life 2022; 12(12): 2130.
28. Marcovich R, Smith AD. Renal pelvic stones: choosing shock wave lithotripsy or percutaneous neph-rolithotomy. Int Braz J Urol 2003; 29(3): 195-207.

Additional Files

Published

2024-03-29